Multiplex Assays Market Analysis by Major Competitors QIAGEN, PerkinElmer Inc., Illumina, Inc., AGENA BIOSCIENCE INC., Olink , Randox Laboratories Ltd., Bio-Techne., Agilent Technologies, Agilent Technologies, Sysmex Corporation and Among Others

A Multiplex Assay is a type of immunoassay that uses magnetic beads or non-magnetic beads to determine multiple analytic in a single sample. A multiplex assay is as similar as that of an ELISA but here in multiplex assays, beads are present that are useful in binding the capture antibody. Multiplex assays are common because of their benefits nowadays in research than in clinical settings.

Global Multiplex Assays Market is expected to register a healthy CAGR of 7.5% in the forecast period of 2019 to 2026. The new market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Get Free Sample Report at http://databridgemarketresearch.com/request-a-sample/?dbmr=global-multiplex-assays-market

ADVANTAGES OVER SINGLEPLEX AND TRADITIONAL ASSAYS:

Multiplex assays are useful for the detection of multiple analytes in a given small sample in research area. Traditional assays such as ELISA and others have certain limitations such as it is tedious/laborious assay procedure and also has insufficient level of sensitivity in bio-recognition of challenging biomolecular entities.

To overcome such problems related to ELISA or others techniques, modification have been done by scientists and the assays are called as multiplex assays which is more beneficial as compared to traditional assays. These assays are used for the detection of multiples analytes in given sample. The MULTI-ARRAY and Bio-Plex platforms are the part of multiplex assays.

INCREASING AWARENESS ABOUT MULTIFACTORIAL NATURE OF VARIOUS DISEASES:

Chronic health conditions are genetic, behavioral, and environmental risk factors. These are an important part of genomic literacy and the people having erroneous beliefs about the multifactorial etiology related to common health conditions may have difficulty in engaging with future prevention and screening recommendations that are developed based on a multifactorial model of disease causation. Common medical problems such as diabetes, heart disease, Alzheimer’s disease, hypertension and obesity do not have a single genetic cause. These diseases are likely associated with the effects of multiple genes in combination with lifestyle and environmental factors.

To Avail 10% Discount On This Report Mail Us on :- sopan.gedam@databridgemarketresearch.com

Global Multiplex Assays Market by Competitive Analysis:

Some of the prominent participants operating in this market are:-

• BD,
• Bio-Rad Laboratories, Inc.,
• Thermo Fisher Scientific Inc.,
• F. Hoffmann-La Roche Ltd,
• Cepheid,
Siemens AG, Hologic Inc., Luminex Corporation. , MESO SCALE DIAGNOSTICS, LLC., QIAGEN, PerkinElmer Inc., Illumina, Inc. , AGENA BIOSCIENCE, INC. , Olink , Randox Laboratories Ltd., Bio-Techne. , Agilent Technologies, Agilent Technologies, Sysmex Corporation and among others.

Market Trends:

On the basis of product & services the market is segmented into reagents & consumables, instruments & accessories and software and services. In 2019, reagents & consumables segment is expected to dominate the global multiplex assays market with 64.1% market share and is expected to growing at the highest CAGR of 7.8% in the forecast period of 2019 to 2026.

On the basis of type, the market is segmented into protein multiplex assays, nucleic acid multiplex assays and cell-based multiplex assays. Protein multiplex assays are sub-segmented into planar protein assays and bead-based protein assays. Nucleic acid multiplex assays are sub-segmented into planar nucleic acid assays and bead-based nucleic acid assays. In 2019, a nucleic acid multiplex assay segment is expected to dominate the global multiplex assays market with 48.5% market share and is expected to grow at the highest CAGR of 8.0% in the forecast period of 2019 to 2026.

On the basis of technology, the market is segmented into flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR, polymerase chain reaction (PCR), protein microarray and others. In 2019, protein microarray segment is expected to dominate the global multiplex assays market with 34.2% market share and is expected to grow at the CAGR of 7.6% in the forecast period of 2019 to 2026. However, polymerase chain reaction (PCR) segment is expected to grow at the highest CAGR of 8.2% in the forecast period of 2019 to 2026.

Access Detailed TOC at https://databridgemarketresearch.com/toc/?dbmr=global-multiplex-assays-market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.